2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment-Authors' reply

Affiliations

¹ Division of Electrophysiology and Cardiac Devices, Department of Cardiology, University Hospital Zurich, Rämistrasse 100, CH-8091 Zurich, Switzerland.
² Antwerp University and University Hospital, Antwerp, Belgium.

Comment

Jan Steffel et al. Europace. 2021.

. 2021 Oct 9;23(10):1685-1686.

doi: 10.1093/europace/euab218.

¹ Division of Electrophysiology and Cardiac Devices, Department of Cardiology, University Hospital Zurich, Rämistrasse 100, CH-8091 Zurich, Switzerland.
² Antwerp University and University Hospital, Antwerp, Belgium.

No abstract available

Comment on

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.
Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Vanassche T, Potpara T, Camm AJ, Heidbüchel H; External reviewers. Steffel J, et al. Europace. 2021 Oct 9;23(10):1612-1676. doi: 10.1093/europace/euab065. Europace. 2021. PMID: 33895845 Free PMC article. No abstract available.
2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment.
Mbroh J, Poli S. Mbroh J, et al. Europace. 2021 Oct 9;23(10):1685. doi: 10.1093/europace/euab217. Europace. 2021. PMID: 34480553 No abstract available.